nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ORM1—Propranolol—migraine	0.0871	0.124	CbGbCtD
Erlotinib—ORM1—Amitriptyline—migraine	0.0754	0.107	CbGbCtD
Erlotinib—CYP1A1—Propranolol—migraine	0.0491	0.07	CbGbCtD
Erlotinib—ABCG2—Verapamil—migraine	0.0365	0.052	CbGbCtD
Erlotinib—ALB—Amitriptyline—migraine	0.0317	0.0452	CbGbCtD
Erlotinib—CYP3A5—Propranolol—migraine	0.0295	0.042	CbGbCtD
Erlotinib—CYP3A5—Amitriptyline—migraine	0.0255	0.0363	CbGbCtD
Erlotinib—CYP2C8—Amitriptyline—migraine	0.0245	0.0349	CbGbCtD
Erlotinib—CYP3A5—Valproic Acid—migraine	0.0232	0.0331	CbGbCtD
Erlotinib—CYP2C8—Valproic Acid—migraine	0.0223	0.0318	CbGbCtD
Erlotinib—CYP1A2—Propranolol—migraine	0.0219	0.0313	CbGbCtD
Erlotinib—ABCB1—Timolol—migraine	0.0215	0.0307	CbGbCtD
Erlotinib—CYP2D6—Timolol—migraine	0.0203	0.0289	CbGbCtD
Erlotinib—CYP3A5—Verapamil—migraine	0.0202	0.0288	CbGbCtD
Erlotinib—CYP2C8—Verapamil—migraine	0.0194	0.0277	CbGbCtD
Erlotinib—ABCB1—Propranolol—migraine	0.0192	0.0273	CbGbCtD
Erlotinib—CYP1A2—Amitriptyline—migraine	0.019	0.027	CbGbCtD
Erlotinib—CYP2D6—Propranolol—migraine	0.0181	0.0258	CbGbCtD
Erlotinib—CYP1A2—Valproic Acid—migraine	0.0173	0.0247	CbGbCtD
Erlotinib—ABCB1—Amitriptyline—migraine	0.0166	0.0237	CbGbCtD
Erlotinib—CYP2D6—Amitriptyline—migraine	0.0156	0.0223	CbGbCtD
Erlotinib—CYP1A2—Verapamil—migraine	0.0151	0.0215	CbGbCtD
Erlotinib—ABCB1—Verapamil—migraine	0.0132	0.0188	CbGbCtD
Erlotinib—CYP2D6—Verapamil—migraine	0.0124	0.0177	CbGbCtD
Erlotinib—CYP3A4—Propranolol—migraine	0.0115	0.0164	CbGbCtD
Erlotinib—CYP3A4—Amitriptyline—migraine	0.00994	0.0142	CbGbCtD
Erlotinib—CYP3A4—Valproic Acid—migraine	0.00906	0.0129	CbGbCtD
Erlotinib—CYP3A4—Topiramate—migraine	0.00817	0.0117	CbGbCtD
Erlotinib—CYP3A4—Verapamil—migraine	0.00788	0.0112	CbGbCtD
Erlotinib—MKNK1—Pindolol—Propranolol—migraine	0.00289	1	CbGdCrCtD
Erlotinib—TNK1—trigeminal ganglion—migraine	0.00209	0.029	CbGeAlD
Erlotinib—PIP4K2C—trigeminal ganglion—migraine	0.00162	0.0225	CbGeAlD
Erlotinib—ULK3—trigeminal ganglion—migraine	0.00155	0.0215	CbGeAlD
Erlotinib—MKNK1—trigeminal ganglion—migraine	0.00146	0.0202	CbGeAlD
Erlotinib—LTK—head—migraine	0.00139	0.0193	CbGeAlD
Erlotinib—NR1I2—head—migraine	0.00139	0.0193	CbGeAlD
Erlotinib—SLK—trigeminal ganglion—migraine	0.00138	0.0191	CbGeAlD
Erlotinib—FLT3—cardiovascular system—migraine	0.0013	0.018	CbGeAlD
Erlotinib—AURKC—head—migraine	0.0012	0.0167	CbGeAlD
Erlotinib—STK10—trigeminal ganglion—migraine	0.0012	0.0166	CbGeAlD
Erlotinib—AURKC—nervous system—migraine	0.00114	0.0158	CbGeAlD
Erlotinib—EPHA6—head—migraine	0.00111	0.0154	CbGeAlD
Erlotinib—JAK3—head—migraine	0.00111	0.0154	CbGeAlD
Erlotinib—AURKC—central nervous system—migraine	0.0011	0.0152	CbGeAlD
Erlotinib—MAP2K5—trigeminal ganglion—migraine	0.00107	0.0149	CbGeAlD
Erlotinib—JAK3—nervous system—migraine	0.00106	0.0146	CbGeAlD
Erlotinib—EPHA6—nervous system—migraine	0.00106	0.0146	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—migraine	0.00105	0.0146	CbGeAlD
Erlotinib—HIPK4—brain—migraine	0.00102	0.0142	CbGeAlD
Erlotinib—JAK3—central nervous system—migraine	0.00102	0.0141	CbGeAlD
Erlotinib—EPHA6—central nervous system—migraine	0.00102	0.0141	CbGeAlD
Erlotinib—MAP3K19—head—migraine	0.00101	0.014	CbGeAlD
Erlotinib—LTK—brain—migraine	0.00101	0.014	CbGeAlD
Erlotinib—JAK3—cerebellum—migraine	0.000994	0.0138	CbGeAlD
Erlotinib—MAP3K19—nervous system—migraine	0.00096	0.0133	CbGeAlD
Erlotinib—MAP2K5—brainstem—migraine	0.000949	0.0132	CbGeAlD
Erlotinib—MAP3K19—central nervous system—migraine	0.000924	0.0128	CbGeAlD
Erlotinib—TNK1—cerebellum—migraine	0.000913	0.0126	CbGeAlD
Erlotinib—AURKC—brain—migraine	0.000872	0.0121	CbGeAlD
Erlotinib—STK10—cardiovascular system—migraine	0.000868	0.012	CbGeAlD
Erlotinib—ABL1—trigeminal ganglion—migraine	0.000828	0.0115	CbGeAlD
Erlotinib—JAK3—brain—migraine	0.000807	0.0112	CbGeAlD
Erlotinib—EPHA6—brain—migraine	0.000807	0.0112	CbGeAlD
Erlotinib—PIP4K2C—head—migraine	0.000794	0.011	CbGeAlD
Erlotinib—FLT3—cerebellum—migraine	0.000784	0.0109	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—migraine	0.000775	0.0107	CbGeAlD
Erlotinib—ULK3—head—migraine	0.000758	0.0105	CbGeAlD
Erlotinib—PIP4K2C—nervous system—migraine	0.000753	0.0104	CbGeAlD
Erlotinib—ABL2—cerebellum—migraine	0.000749	0.0104	CbGeAlD
Erlotinib—TNK1—brain—migraine	0.000741	0.0103	CbGeAlD
Erlotinib—MAP3K19—brain—migraine	0.000734	0.0102	CbGeAlD
Erlotinib—ABL1—brainstem—migraine	0.000732	0.0102	CbGeAlD
Erlotinib—EGFR—cerebellum—migraine	0.000731	0.0101	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—migraine	0.000725	0.01	CbGeAlD
Erlotinib—ULK3—nervous system—migraine	0.000719	0.00996	CbGeAlD
Erlotinib—MKNK1—head—migraine	0.000713	0.00989	CbGeAlD
Erlotinib—PIP4K2C—cerebellum—migraine	0.000708	0.00982	CbGeAlD
Erlotinib—ULK3—central nervous system—migraine	0.000692	0.00959	CbGeAlD
Erlotinib—MKNK1—nervous system—migraine	0.000676	0.00937	CbGeAlD
Erlotinib—ULK3—cerebellum—migraine	0.000676	0.00937	CbGeAlD
Erlotinib—MKNK1—central nervous system—migraine	0.000651	0.00903	CbGeAlD
Erlotinib—MKNK1—cerebellum—migraine	0.000637	0.00882	CbGeAlD
Erlotinib—ABL2—brain—migraine	0.000608	0.00843	CbGeAlD
Erlotinib—SLK—cerebellum—migraine	0.000603	0.00835	CbGeAlD
Erlotinib—ABL1—cardiovascular system—migraine	0.000598	0.00828	CbGeAlD
Erlotinib—EGFR—brain—migraine	0.000593	0.00822	CbGeAlD
Erlotinib—STK10—head—migraine	0.000588	0.00814	CbGeAlD
Erlotinib—PIP4K2C—brain—migraine	0.000575	0.00797	CbGeAlD
Erlotinib—STK10—nervous system—migraine	0.000557	0.00772	CbGeAlD
Erlotinib—ULK3—brain—migraine	0.000549	0.00761	CbGeAlD
Erlotinib—STK10—central nervous system—migraine	0.000536	0.00743	CbGeAlD
Erlotinib—MAP2K5—head—migraine	0.000525	0.00727	CbGeAlD
Erlotinib—STK10—cerebellum—migraine	0.000524	0.00726	CbGeAlD
Erlotinib—ABCG2—trigeminal ganglion—migraine	0.000522	0.00723	CbGeAlD
Erlotinib—MKNK1—brain—migraine	0.000517	0.00717	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—migraine	0.000506	0.00702	CbGeAlD
Erlotinib—MAP2K5—nervous system—migraine	0.000497	0.00689	CbGeAlD
Erlotinib—SLK—brain—migraine	0.00049	0.00679	CbGeAlD
Erlotinib—MAP2K5—central nervous system—migraine	0.000479	0.00664	CbGeAlD
Erlotinib—MAP2K5—cerebellum—migraine	0.000468	0.00649	CbGeAlD
Erlotinib—STK10—brain—migraine	0.000426	0.0059	CbGeAlD
Erlotinib—Pneumonia—Gabapentin—migraine	0.000424	0.00238	CcSEcCtD
Erlotinib—Infestation NOS—Gabapentin—migraine	0.000421	0.00237	CcSEcCtD
Erlotinib—Infestation—Gabapentin—migraine	0.000421	0.00237	CcSEcCtD
Erlotinib—Depression—Gabapentin—migraine	0.00042	0.00236	CcSEcCtD
Erlotinib—Hypokalaemia—Topiramate—migraine	0.000418	0.00235	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Gabapentin—migraine	0.000418	0.00235	CcSEcCtD
Erlotinib—Diarrhoea—Amitriptyline—migraine	0.000417	0.00235	CcSEcCtD
Erlotinib—ABCB1—blood vessel—migraine	0.000417	0.00577	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Verapamil—migraine	0.000416	0.00234	CcSEcCtD
Erlotinib—Acute coronary syndrome—Gabapentin—migraine	0.000415	0.00233	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Topiramate—migraine	0.000414	0.00233	CcSEcCtD
Erlotinib—Renal failure—Gabapentin—migraine	0.000414	0.00233	CcSEcCtD
Erlotinib—Insomnia—Verapamil—migraine	0.000413	0.00232	CcSEcCtD
Erlotinib—Myocardial infarction—Gabapentin—migraine	0.000413	0.00232	CcSEcCtD
Erlotinib—Neuropathy peripheral—Gabapentin—migraine	0.000413	0.00232	CcSEcCtD
Erlotinib—Mediastinal disorder—Valproic Acid—migraine	0.000411	0.00231	CcSEcCtD
Erlotinib—Stomatitis—Gabapentin—migraine	0.000411	0.00231	CcSEcCtD
Erlotinib—Conjunctivitis—Gabapentin—migraine	0.000409	0.0023	CcSEcCtD
Erlotinib—Chills—Valproic Acid—migraine	0.000409	0.0023	CcSEcCtD
Erlotinib—SLCO2B1—head—migraine	0.000408	0.00566	CbGeAlD
Erlotinib—Arrhythmia—Valproic Acid—migraine	0.000407	0.00229	CcSEcCtD
Erlotinib—Dyspnoea—Verapamil—migraine	0.000407	0.00229	CcSEcCtD
Erlotinib—Gastritis—Topiramate—migraine	0.000407	0.00229	CcSEcCtD
Erlotinib—Gastrointestinal pain—Propranolol—migraine	0.000406	0.00228	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Topiramate—migraine	0.000406	0.00228	CcSEcCtD
Erlotinib—ABL1—head—migraine	0.000405	0.00561	CbGeAlD
Erlotinib—ORM1—nervous system—migraine	0.000404	0.0056	CbGeAlD
Erlotinib—Dizziness—Amitriptyline—migraine	0.000403	0.00227	CcSEcCtD
Erlotinib—Alopecia—Valproic Acid—migraine	0.000403	0.00227	CcSEcCtD
Erlotinib—Dyspepsia—Verapamil—migraine	0.000402	0.00226	CcSEcCtD
Erlotinib—Mental disorder—Valproic Acid—migraine	0.0004	0.00225	CcSEcCtD
Erlotinib—Connective tissue disorder—Timolol—migraine	0.000399	0.00224	CcSEcCtD
Erlotinib—Hepatobiliary disease—Gabapentin—migraine	0.000398	0.00224	CcSEcCtD
Erlotinib—Dysphagia—Topiramate—migraine	0.000397	0.00223	CcSEcCtD
Erlotinib—Epistaxis—Gabapentin—migraine	0.000397	0.00223	CcSEcCtD
Erlotinib—Malnutrition—Valproic Acid—migraine	0.000397	0.00223	CcSEcCtD
Erlotinib—Fatigue—Verapamil—migraine	0.000394	0.00221	CcSEcCtD
Erlotinib—Body temperature increased—Propranolol—migraine	0.000393	0.00221	CcSEcCtD
Erlotinib—Abdominal pain—Propranolol—migraine	0.000393	0.00221	CcSEcCtD
Erlotinib—Flatulence—Valproic Acid—migraine	0.000391	0.0022	CcSEcCtD
Erlotinib—Constipation—Verapamil—migraine	0.000391	0.0022	CcSEcCtD
Erlotinib—Pain—Verapamil—migraine	0.000391	0.0022	CcSEcCtD
Erlotinib—Pancreatitis—Topiramate—migraine	0.00039	0.00219	CcSEcCtD
Erlotinib—ORM1—central nervous system—migraine	0.000389	0.00539	CbGeAlD
Erlotinib—Vomiting—Amitriptyline—migraine	0.000388	0.00218	CcSEcCtD
Erlotinib—SLCO2B1—nervous system—migraine	0.000387	0.00536	CbGeAlD
Erlotinib—Rash—Amitriptyline—migraine	0.000385	0.00216	CcSEcCtD
Erlotinib—Dermatitis—Amitriptyline—migraine	0.000384	0.00216	CcSEcCtD
Erlotinib—Back pain—Valproic Acid—migraine	0.000384	0.00216	CcSEcCtD
Erlotinib—ABL1—nervous system—migraine	0.000384	0.00532	CbGeAlD
Erlotinib—Headache—Amitriptyline—migraine	0.000382	0.00215	CcSEcCtD
Erlotinib—MAP2K5—brain—migraine	0.00038	0.00527	CbGeAlD
Erlotinib—Eye disorder—Timolol—migraine	0.000379	0.00213	CcSEcCtD
Erlotinib—Haemorrhage—Gabapentin—migraine	0.000378	0.00213	CcSEcCtD
Erlotinib—Hepatitis—Gabapentin—migraine	0.000378	0.00213	CcSEcCtD
Erlotinib—Urinary tract disorder—Gabapentin—migraine	0.000373	0.0021	CcSEcCtD
Erlotinib—SLCO2B1—central nervous system—migraine	0.000373	0.00516	CbGeAlD
Erlotinib—Neutropenia—Topiramate—migraine	0.000372	0.00209	CcSEcCtD
Erlotinib—Connective tissue disorder—Gabapentin—migraine	0.000372	0.00209	CcSEcCtD
Erlotinib—Urethral disorder—Gabapentin—migraine	0.000371	0.00208	CcSEcCtD
Erlotinib—ABL1—central nervous system—migraine	0.000369	0.00512	CbGeAlD
Erlotinib—Mediastinal disorder—Timolol—migraine	0.000366	0.00206	CcSEcCtD
Erlotinib—SLCO2B1—cerebellum—migraine	0.000364	0.00505	CbGeAlD
Erlotinib—Arrhythmia—Timolol—migraine	0.000363	0.00204	CcSEcCtD
Erlotinib—Nausea—Amitriptyline—migraine	0.000362	0.00204	CcSEcCtD
Erlotinib—ABL1—cerebellum—migraine	0.000361	0.005	CbGeAlD
Erlotinib—Weight decreased—Topiramate—migraine	0.00036	0.00202	CcSEcCtD
Erlotinib—Alopecia—Timolol—migraine	0.000359	0.00202	CcSEcCtD
Erlotinib—Erythema multiforme—Gabapentin—migraine	0.000358	0.00201	CcSEcCtD
Erlotinib—Asthenia—Propranolol—migraine	0.000356	0.002	CcSEcCtD
Erlotinib—Pneumonia—Topiramate—migraine	0.000356	0.002	CcSEcCtD
Erlotinib—Mental disorder—Timolol—migraine	0.000356	0.002	CcSEcCtD
Erlotinib—Infestation NOS—Topiramate—migraine	0.000354	0.00199	CcSEcCtD
Erlotinib—Infestation—Topiramate—migraine	0.000354	0.00199	CcSEcCtD
Erlotinib—Malnutrition—Timolol—migraine	0.000353	0.00199	CcSEcCtD
Erlotinib—Erythema—Timolol—migraine	0.000353	0.00199	CcSEcCtD
Erlotinib—Eye disorder—Gabapentin—migraine	0.000353	0.00199	CcSEcCtD
Erlotinib—Depression—Topiramate—migraine	0.000353	0.00199	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Topiramate—migraine	0.000351	0.00197	CcSEcCtD
Erlotinib—Renal failure—Topiramate—migraine	0.000348	0.00196	CcSEcCtD
Erlotinib—Neuropathy peripheral—Topiramate—migraine	0.000347	0.00195	CcSEcCtD
Erlotinib—Cough—Valproic Acid—migraine	0.000346	0.00195	CcSEcCtD
Erlotinib—Stomatitis—Topiramate—migraine	0.000345	0.00194	CcSEcCtD
Erlotinib—Conjunctivitis—Topiramate—migraine	0.000344	0.00194	CcSEcCtD
Erlotinib—CYP1B1—head—migraine	0.000343	0.00475	CbGeAlD
Erlotinib—Mediastinal disorder—Gabapentin—migraine	0.000341	0.00192	CcSEcCtD
Erlotinib—Diarrhoea—Propranolol—migraine	0.00034	0.00191	CcSEcCtD
Erlotinib—Chills—Gabapentin—migraine	0.000339	0.00191	CcSEcCtD
Erlotinib—Myalgia—Valproic Acid—migraine	0.000338	0.0019	CcSEcCtD
Erlotinib—Chest pain—Valproic Acid—migraine	0.000338	0.0019	CcSEcCtD
Erlotinib—Arthralgia—Valproic Acid—migraine	0.000338	0.0019	CcSEcCtD
Erlotinib—Anxiety—Valproic Acid—migraine	0.000337	0.00189	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000336	0.00189	CcSEcCtD
Erlotinib—Epistaxis—Topiramate—migraine	0.000334	0.00188	CcSEcCtD
Erlotinib—Alopecia—Gabapentin—migraine	0.000334	0.00188	CcSEcCtD
Erlotinib—Mental disorder—Gabapentin—migraine	0.000331	0.00186	CcSEcCtD
Erlotinib—Malnutrition—Gabapentin—migraine	0.000329	0.00185	CcSEcCtD
Erlotinib—Erythema—Gabapentin—migraine	0.000329	0.00185	CcSEcCtD
Erlotinib—Dizziness—Propranolol—migraine	0.000329	0.00185	CcSEcCtD
Erlotinib—Asthenia—Verapamil—migraine	0.000328	0.00184	CcSEcCtD
Erlotinib—CYP1B1—nervous system—migraine	0.000325	0.0045	CbGeAlD
Erlotinib—Flatulence—Gabapentin—migraine	0.000324	0.00182	CcSEcCtD
Erlotinib—Oedema—Valproic Acid—migraine	0.000324	0.00182	CcSEcCtD
Erlotinib—Pruritus—Verapamil—migraine	0.000323	0.00182	CcSEcCtD
Erlotinib—Infection—Valproic Acid—migraine	0.000322	0.00181	CcSEcCtD
Erlotinib—Haemoglobin—Topiramate—migraine	0.00032	0.0018	CcSEcCtD
Erlotinib—Back pain—Gabapentin—migraine	0.000318	0.00179	CcSEcCtD
Erlotinib—Haemorrhage—Topiramate—migraine	0.000318	0.00179	CcSEcCtD
Erlotinib—Hepatitis—Topiramate—migraine	0.000318	0.00179	CcSEcCtD
Erlotinib—Nervous system disorder—Valproic Acid—migraine	0.000318	0.00179	CcSEcCtD
Erlotinib—Thrombocytopenia—Valproic Acid—migraine	0.000317	0.00178	CcSEcCtD
Erlotinib—Syncope—Timolol—migraine	0.000317	0.00178	CcSEcCtD
Erlotinib—CYP2D6—brainstem—migraine	0.000317	0.00439	CbGeAlD
Erlotinib—Vomiting—Propranolol—migraine	0.000316	0.00178	CcSEcCtD
Erlotinib—Skin disorder—Valproic Acid—migraine	0.000315	0.00177	CcSEcCtD
Erlotinib—Urinary tract disorder—Topiramate—migraine	0.000314	0.00177	CcSEcCtD
Erlotinib—Rash—Propranolol—migraine	0.000313	0.00176	CcSEcCtD
Erlotinib—Dermatitis—Propranolol—migraine	0.000313	0.00176	CcSEcCtD
Erlotinib—CYP1B1—central nervous system—migraine	0.000313	0.00434	CbGeAlD
Erlotinib—Diarrhoea—Verapamil—migraine	0.000313	0.00176	CcSEcCtD
Erlotinib—Connective tissue disorder—Topiramate—migraine	0.000313	0.00176	CcSEcCtD
Erlotinib—Urethral disorder—Topiramate—migraine	0.000312	0.00175	CcSEcCtD
Erlotinib—Loss of consciousness—Timolol—migraine	0.000311	0.00175	CcSEcCtD
Erlotinib—Anorexia—Valproic Acid—migraine	0.000309	0.00174	CcSEcCtD
Erlotinib—Cough—Timolol—migraine	0.000308	0.00173	CcSEcCtD
Erlotinib—CYP1B1—cerebellum—migraine	0.000306	0.00424	CbGeAlD
Erlotinib—Dizziness—Verapamil—migraine	0.000302	0.0017	CcSEcCtD
Erlotinib—Chest pain—Timolol—migraine	0.000301	0.00169	CcSEcCtD
Erlotinib—Arthralgia—Timolol—migraine	0.000301	0.00169	CcSEcCtD
Erlotinib—Myalgia—Timolol—migraine	0.000301	0.00169	CcSEcCtD
Erlotinib—Erythema multiforme—Topiramate—migraine	0.000301	0.00169	CcSEcCtD
Erlotinib—Anxiety—Timolol—migraine	0.0003	0.00169	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000299	0.00168	CcSEcCtD
Erlotinib—Eye disorder—Topiramate—migraine	0.000297	0.00167	CcSEcCtD
Erlotinib—SLCO2B1—brain—migraine	0.000296	0.0041	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Valproic Acid—migraine	0.000295	0.00166	CcSEcCtD
Erlotinib—Syncope—Gabapentin—migraine	0.000295	0.00166	CcSEcCtD
Erlotinib—Nausea—Propranolol—migraine	0.000295	0.00166	CcSEcCtD
Erlotinib—ABL1—brain—migraine	0.000293	0.00406	CbGeAlD
Erlotinib—Insomnia—Valproic Acid—migraine	0.000293	0.00165	CcSEcCtD
Erlotinib—Vomiting—Verapamil—migraine	0.000291	0.00163	CcSEcCtD
Erlotinib—Loss of consciousness—Gabapentin—migraine	0.000289	0.00163	CcSEcCtD
Erlotinib—Dyspnoea—Valproic Acid—migraine	0.000289	0.00162	CcSEcCtD
Erlotinib—Oedema—Timolol—migraine	0.000288	0.00162	CcSEcCtD
Erlotinib—Rash—Verapamil—migraine	0.000288	0.00162	CcSEcCtD
Erlotinib—Dermatitis—Verapamil—migraine	0.000288	0.00162	CcSEcCtD
Erlotinib—Cough—Gabapentin—migraine	0.000287	0.00161	CcSEcCtD
Erlotinib—Mediastinal disorder—Topiramate—migraine	0.000287	0.00161	CcSEcCtD
Erlotinib—Infection—Timolol—migraine	0.000287	0.00161	CcSEcCtD
Erlotinib—Headache—Verapamil—migraine	0.000286	0.00161	CcSEcCtD
Erlotinib—Chills—Topiramate—migraine	0.000285	0.0016	CcSEcCtD
Erlotinib—Dyspepsia—Valproic Acid—migraine	0.000285	0.0016	CcSEcCtD
Erlotinib—Shock—Timolol—migraine	0.000284	0.0016	CcSEcCtD
Erlotinib—Nervous system disorder—Timolol—migraine	0.000283	0.00159	CcSEcCtD
Erlotinib—Decreased appetite—Valproic Acid—migraine	0.000282	0.00158	CcSEcCtD
Erlotinib—Alopecia—Topiramate—migraine	0.000281	0.00158	CcSEcCtD
Erlotinib—Chest pain—Gabapentin—migraine	0.00028	0.00158	CcSEcCtD
Erlotinib—Myalgia—Gabapentin—migraine	0.00028	0.00158	CcSEcCtD
Erlotinib—Arthralgia—Gabapentin—migraine	0.00028	0.00158	CcSEcCtD
Erlotinib—Skin disorder—Timolol—migraine	0.00028	0.00157	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Valproic Acid—migraine	0.00028	0.00157	CcSEcCtD
Erlotinib—Fatigue—Valproic Acid—migraine	0.000279	0.00157	CcSEcCtD
Erlotinib—Anxiety—Gabapentin—migraine	0.000279	0.00157	CcSEcCtD
Erlotinib—Mental disorder—Topiramate—migraine	0.000279	0.00157	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000278	0.00156	CcSEcCtD
Erlotinib—Constipation—Valproic Acid—migraine	0.000277	0.00156	CcSEcCtD
Erlotinib—Pain—Valproic Acid—migraine	0.000277	0.00156	CcSEcCtD
Erlotinib—Erythema—Topiramate—migraine	0.000277	0.00156	CcSEcCtD
Erlotinib—Malnutrition—Topiramate—migraine	0.000277	0.00156	CcSEcCtD
Erlotinib—Anorexia—Timolol—migraine	0.000275	0.00155	CcSEcCtD
Erlotinib—Flatulence—Topiramate—migraine	0.000273	0.00153	CcSEcCtD
Erlotinib—Nausea—Verapamil—migraine	0.000271	0.00153	CcSEcCtD
Erlotinib—ALB—brain—migraine	0.000271	0.00375	CbGeAlD
Erlotinib—Oedema—Gabapentin—migraine	0.000269	0.00151	CcSEcCtD
Erlotinib—Back pain—Topiramate—migraine	0.000268	0.00151	CcSEcCtD
Erlotinib—Infection—Gabapentin—migraine	0.000267	0.0015	CcSEcCtD
Erlotinib—Gastrointestinal pain—Valproic Acid—migraine	0.000265	0.00149	CcSEcCtD
Erlotinib—Shock—Gabapentin—migraine	0.000264	0.00149	CcSEcCtD
Erlotinib—Nervous system disorder—Gabapentin—migraine	0.000263	0.00148	CcSEcCtD
Erlotinib—Thrombocytopenia—Gabapentin—migraine	0.000263	0.00148	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Timolol—migraine	0.000263	0.00148	CcSEcCtD
Erlotinib—Skin disorder—Gabapentin—migraine	0.000261	0.00147	CcSEcCtD
Erlotinib—Insomnia—Timolol—migraine	0.000261	0.00147	CcSEcCtD
Erlotinib—ABCB1—trigeminal ganglion—migraine	0.000257	0.00357	CbGeAlD
Erlotinib—Dyspnoea—Timolol—migraine	0.000257	0.00145	CcSEcCtD
Erlotinib—Body temperature increased—Valproic Acid—migraine	0.000256	0.00144	CcSEcCtD
Erlotinib—Abdominal pain—Valproic Acid—migraine	0.000256	0.00144	CcSEcCtD
Erlotinib—Anorexia—Gabapentin—migraine	0.000256	0.00144	CcSEcCtD
Erlotinib—Dyspepsia—Timolol—migraine	0.000254	0.00143	CcSEcCtD
Erlotinib—Decreased appetite—Timolol—migraine	0.000251	0.00141	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Timolol—migraine	0.000249	0.0014	CcSEcCtD
Erlotinib—Fatigue—Timolol—migraine	0.000249	0.0014	CcSEcCtD
Erlotinib—CYP1B1—brain—migraine	0.000248	0.00344	CbGeAlD
Erlotinib—Syncope—Topiramate—migraine	0.000248	0.0014	CcSEcCtD
Erlotinib—Pain—Timolol—migraine	0.000247	0.00139	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Gabapentin—migraine	0.000245	0.00138	CcSEcCtD
Erlotinib—Loss of consciousness—Topiramate—migraine	0.000243	0.00137	CcSEcCtD
Erlotinib—Insomnia—Gabapentin—migraine	0.000243	0.00137	CcSEcCtD
Erlotinib—CYP1A1—head—migraine	0.000242	0.00336	CbGeAlD
Erlotinib—Cough—Topiramate—migraine	0.000242	0.00136	CcSEcCtD
Erlotinib—Dyspnoea—Gabapentin—migraine	0.000239	0.00135	CcSEcCtD
Erlotinib—Dyspepsia—Gabapentin—migraine	0.000236	0.00133	CcSEcCtD
Erlotinib—Gastrointestinal pain—Timolol—migraine	0.000236	0.00133	CcSEcCtD
Erlotinib—Myalgia—Topiramate—migraine	0.000236	0.00133	CcSEcCtD
Erlotinib—Chest pain—Topiramate—migraine	0.000236	0.00133	CcSEcCtD
Erlotinib—Arthralgia—Topiramate—migraine	0.000236	0.00133	CcSEcCtD
Erlotinib—Anxiety—Topiramate—migraine	0.000235	0.00132	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000234	0.00132	CcSEcCtD
Erlotinib—Decreased appetite—Gabapentin—migraine	0.000234	0.00131	CcSEcCtD
Erlotinib—Asthenia—Valproic Acid—migraine	0.000232	0.00131	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Gabapentin—migraine	0.000232	0.0013	CcSEcCtD
Erlotinib—Fatigue—Gabapentin—migraine	0.000232	0.0013	CcSEcCtD
Erlotinib—CYP1A1—nervous system—migraine	0.00023	0.00318	CbGeAlD
Erlotinib—Constipation—Gabapentin—migraine	0.00023	0.00129	CcSEcCtD
Erlotinib—Pain—Gabapentin—migraine	0.00023	0.00129	CcSEcCtD
Erlotinib—Pruritus—Valproic Acid—migraine	0.000229	0.00129	CcSEcCtD
Erlotinib—Abdominal pain—Timolol—migraine	0.000228	0.00128	CcSEcCtD
Erlotinib—Body temperature increased—Timolol—migraine	0.000228	0.00128	CcSEcCtD
Erlotinib—ABCG2—cerebellum—migraine	0.000228	0.00316	CbGeAlD
Erlotinib—Oedema—Topiramate—migraine	0.000226	0.00127	CcSEcCtD
Erlotinib—Infection—Topiramate—migraine	0.000225	0.00126	CcSEcCtD
Erlotinib—Shock—Topiramate—migraine	0.000222	0.00125	CcSEcCtD
Erlotinib—Diarrhoea—Valproic Acid—migraine	0.000222	0.00125	CcSEcCtD
Erlotinib—Nervous system disorder—Topiramate—migraine	0.000222	0.00125	CcSEcCtD
Erlotinib—Thrombocytopenia—Topiramate—migraine	0.000221	0.00124	CcSEcCtD
Erlotinib—CYP1A1—central nervous system—migraine	0.000221	0.00307	CbGeAlD
Erlotinib—Gastrointestinal pain—Gabapentin—migraine	0.00022	0.00123	CcSEcCtD
Erlotinib—Skin disorder—Topiramate—migraine	0.00022	0.00123	CcSEcCtD
Erlotinib—Anorexia—Topiramate—migraine	0.000215	0.00121	CcSEcCtD
Erlotinib—Dizziness—Valproic Acid—migraine	0.000214	0.0012	CcSEcCtD
Erlotinib—Abdominal pain—Gabapentin—migraine	0.000212	0.00119	CcSEcCtD
Erlotinib—Body temperature increased—Gabapentin—migraine	0.000212	0.00119	CcSEcCtD
Erlotinib—Asthenia—Timolol—migraine	0.000207	0.00116	CcSEcCtD
Erlotinib—Vomiting—Valproic Acid—migraine	0.000206	0.00116	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Topiramate—migraine	0.000206	0.00116	CcSEcCtD
Erlotinib—Insomnia—Topiramate—migraine	0.000204	0.00115	CcSEcCtD
Erlotinib—Rash—Valproic Acid—migraine	0.000204	0.00115	CcSEcCtD
Erlotinib—Dermatitis—Valproic Acid—migraine	0.000204	0.00115	CcSEcCtD
Erlotinib—Pruritus—Timolol—migraine	0.000204	0.00115	CcSEcCtD
Erlotinib—Headache—Valproic Acid—migraine	0.000203	0.00114	CcSEcCtD
Erlotinib—Dyspnoea—Topiramate—migraine	0.000201	0.00113	CcSEcCtD
Erlotinib—Dyspepsia—Topiramate—migraine	0.000199	0.00112	CcSEcCtD
Erlotinib—Diarrhoea—Timolol—migraine	0.000197	0.00111	CcSEcCtD
Erlotinib—Decreased appetite—Topiramate—migraine	0.000196	0.0011	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Topiramate—migraine	0.000195	0.0011	CcSEcCtD
Erlotinib—Fatigue—Topiramate—migraine	0.000195	0.0011	CcSEcCtD
Erlotinib—Pain—Topiramate—migraine	0.000193	0.00109	CcSEcCtD
Erlotinib—Constipation—Topiramate—migraine	0.000193	0.00109	CcSEcCtD
Erlotinib—Asthenia—Gabapentin—migraine	0.000193	0.00108	CcSEcCtD
Erlotinib—Nausea—Valproic Acid—migraine	0.000192	0.00108	CcSEcCtD
Erlotinib—Dizziness—Timolol—migraine	0.000191	0.00107	CcSEcCtD
Erlotinib—CYP2C8—brain—migraine	0.00019	0.00264	CbGeAlD
Erlotinib—Pruritus—Gabapentin—migraine	0.00019	0.00107	CcSEcCtD
Erlotinib—ABCB1—cardiovascular system—migraine	0.000186	0.00258	CbGeAlD
Erlotinib—ABCG2—brain—migraine	0.000185	0.00256	CbGeAlD
Erlotinib—Gastrointestinal pain—Topiramate—migraine	0.000185	0.00104	CcSEcCtD
Erlotinib—Diarrhoea—Gabapentin—migraine	0.000184	0.00103	CcSEcCtD
Erlotinib—Vomiting—Timolol—migraine	0.000183	0.00103	CcSEcCtD
Erlotinib—Rash—Timolol—migraine	0.000182	0.00102	CcSEcCtD
Erlotinib—Dermatitis—Timolol—migraine	0.000182	0.00102	CcSEcCtD
Erlotinib—Headache—Timolol—migraine	0.000181	0.00102	CcSEcCtD
Erlotinib—Body temperature increased—Topiramate—migraine	0.000179	0.001	CcSEcCtD
Erlotinib—Abdominal pain—Topiramate—migraine	0.000179	0.001	CcSEcCtD
Erlotinib—Dizziness—Gabapentin—migraine	0.000178	0.000998	CcSEcCtD
Erlotinib—CYP1A1—brain—migraine	0.000176	0.00243	CbGeAlD
Erlotinib—CYP2D6—head—migraine	0.000175	0.00242	CbGeAlD
Erlotinib—Nausea—Timolol—migraine	0.000171	0.000963	CcSEcCtD
Erlotinib—Vomiting—Gabapentin—migraine	0.000171	0.00096	CcSEcCtD
Erlotinib—Rash—Gabapentin—migraine	0.000169	0.000952	CcSEcCtD
Erlotinib—Dermatitis—Gabapentin—migraine	0.000169	0.000951	CcSEcCtD
Erlotinib—CYP3A4—nervous system—migraine	0.000169	0.00234	CbGeAlD
Erlotinib—Headache—Gabapentin—migraine	0.000168	0.000946	CcSEcCtD
Erlotinib—MAP2K5—MAPK Signaling Pathway—BDNF—migraine	0.000168	0.00366	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—NOTCH4—migraine	0.000167	0.00363	CbGpPWpGaD
Erlotinib—CYP2D6—nervous system—migraine	0.000166	0.0023	CbGeAlD
Erlotinib—MAP2K5—ErbB1 downstream signaling—FOS—migraine	0.000165	0.0036	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CALCRL—migraine	0.000164	0.00359	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—RAMP1—migraine	0.000164	0.00359	CbGpPWpGaD
Erlotinib—ABL1—Regulation of Telomerase—ESR1—migraine	0.000163	0.00355	CbGpPWpGaD
Erlotinib—CYP3A4—central nervous system—migraine	0.000162	0.00225	CbGeAlD
Erlotinib—Asthenia—Topiramate—migraine	0.000162	0.000911	CcSEcCtD
Erlotinib—Pruritus—Topiramate—migraine	0.00016	0.000899	CcSEcCtD
Erlotinib—CYP2D6—central nervous system—migraine	0.00016	0.00221	CbGeAlD
Erlotinib—EGFR—Axon guidance—SCN2A—migraine	0.00016	0.00348	CbGpPWpGaD
Erlotinib—Nausea—Gabapentin—migraine	0.00016	0.000897	CcSEcCtD
Erlotinib—ABL1—Developmental Biology—SCN1A—migraine	0.000157	0.00342	CbGpPWpGaD
Erlotinib—CYP2D6—cerebellum—migraine	0.000156	0.00216	CbGeAlD
Erlotinib—Diarrhoea—Topiramate—migraine	0.000155	0.000869	CcSEcCtD
Erlotinib—UGT1A1—NRF2 pathway—SLC6A4—migraine	0.000153	0.00333	CbGpPWpGaD
Erlotinib—CYP1A1—Oxidative Stress—FOS—migraine	0.000152	0.00333	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—PGR—migraine	0.000152	0.00332	CbGpPWpGaD
Erlotinib—Dizziness—Topiramate—migraine	0.000149	0.00084	CcSEcCtD
Erlotinib—MAP2K5—Cardiac Hypertrophic Response—TNF—migraine	0.000149	0.00325	CbGpPWpGaD
Erlotinib—ABL1—Regulation of Telomerase—FOS—migraine	0.000147	0.0032	CbGpPWpGaD
Erlotinib—Vomiting—Topiramate—migraine	0.000144	0.000808	CcSEcCtD
Erlotinib—Rash—Topiramate—migraine	0.000142	0.000801	CcSEcCtD
Erlotinib—Dermatitis—Topiramate—migraine	0.000142	0.0008	CcSEcCtD
Erlotinib—Headache—Topiramate—migraine	0.000142	0.000796	CcSEcCtD
Erlotinib—NR1I2—Generic Transcription Pathway—NOTCH3—migraine	0.000142	0.00309	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—TRPM8—migraine	0.00014	0.00306	CbGpPWpGaD
Erlotinib—EGFR—Regulation of Telomerase—ESR1—migraine	0.000139	0.00304	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—PGR—migraine	0.000137	0.00299	CbGpPWpGaD
Erlotinib—Nausea—Topiramate—migraine	0.000134	0.000755	CcSEcCtD
Erlotinib—EGFR—Developmental Biology—SCN1A—migraine	0.000134	0.00292	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—SCN2A—migraine	0.000133	0.00291	CbGpPWpGaD
Erlotinib—EGFR—LPA receptor mediated events—FOS—migraine	0.000132	0.00287	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR1D—migraine	0.000132	0.00287	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—RAMP1—migraine	0.000129	0.00281	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CALCRL—migraine	0.000129	0.00281	CbGpPWpGaD
Erlotinib—MAP2K5—BDNF signaling pathway—FOS—migraine	0.000128	0.0028	CbGpPWpGaD
Erlotinib—CYP2D6—brain—migraine	0.000127	0.00176	CbGeAlD
Erlotinib—ABCB1—head—migraine	0.000126	0.00174	CbGeAlD
Erlotinib—EGFR—Regulation of Telomerase—FOS—migraine	0.000125	0.00274	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR2B—migraine	0.000122	0.00267	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MEF2D—migraine	0.000122	0.00266	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.00012	0.00262	CbGpPWpGaD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—FOS—migraine	0.00012	0.00262	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR1D—migraine	0.000119	0.00261	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—BDNF—migraine	0.000119	0.0026	CbGpPWpGaD
Erlotinib—ABCB1—nervous system—migraine	0.000119	0.00165	CbGeAlD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000119	0.0026	CbGpPWpGaD
Erlotinib—MAP2K5—Insulin Signaling—FOS—migraine	0.000118	0.00257	CbGpPWpGaD
Erlotinib—MAP2K5—EGF/EGFR Signaling Pathway—FOS—migraine	0.000117	0.00255	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—TGFBR2—migraine	0.000115	0.00251	CbGpPWpGaD
Erlotinib—ABCB1—central nervous system—migraine	0.000115	0.00159	CbGeAlD
Erlotinib—EGFR—Developmental Biology—SCN2A—migraine	0.000114	0.00248	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000113	0.00248	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—FOS—migraine	0.000113	0.00247	CbGpPWpGaD
Erlotinib—ABCB1—cerebellum—migraine	0.000112	0.00156	CbGeAlD
Erlotinib—JAK3—Signaling by GPCR—HTR2B—migraine	0.000111	0.00242	CbGpPWpGaD
Erlotinib—MKNK1—Disease—LRP1—migraine	0.000109	0.00239	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000106	0.00232	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000106	0.00232	CbGpPWpGaD
Erlotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000106	0.00231	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MEF2D—migraine	0.000104	0.00227	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000104	0.00226	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000104	0.00226	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000102	0.00222	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000102	0.00222	CbGpPWpGaD
Erlotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000101	0.00221	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—TNF—migraine	9.91e-05	0.00216	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	9.9e-05	0.00216	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CALCRL—migraine	9.71e-05	0.00212	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RAMP1—migraine	9.71e-05	0.00212	CbGpPWpGaD
Erlotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—migraine	9.63e-05	0.0021	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	9.5e-05	0.00207	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	9.45e-05	0.00206	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—TNF—migraine	9.45e-05	0.00206	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR1D—migraine	9.36e-05	0.00204	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TGFBR2—migraine	9.35e-05	0.00204	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—MTHFR—migraine	9.23e-05	0.00201	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—TNF—migraine	9.21e-05	0.00201	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	9.21e-05	0.00201	CbGpPWpGaD
Erlotinib—ABCB1—brain—migraine	9.12e-05	0.00126	CbGeAlD
Erlotinib—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	9.03e-05	0.00197	CbGpPWpGaD
Erlotinib—ABL1—PDGFR-beta signaling pathway—FOS—migraine	9.01e-05	0.00197	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—BDNF—migraine	9e-05	0.00196	CbGpPWpGaD
Erlotinib—EGFR—ErbB1 downstream signaling—FOS—migraine	8.86e-05	0.00193	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2B—migraine	8.7e-05	0.0019	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—TRPM8—migraine	8.64e-05	0.00189	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—ESR1—migraine	8.6e-05	0.00188	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—ESR1—migraine	8.13e-05	0.00177	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	8.12e-05	0.00177	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—FOS—migraine	8.07e-05	0.00176	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—NOTCH4—migraine	8.02e-05	0.00175	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR1B—migraine	7.97e-05	0.00174	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RAMP1—migraine	7.92e-05	0.00173	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CALCRL—migraine	7.92e-05	0.00173	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR1A—migraine	7.67e-05	0.00167	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	7.66e-05	0.00167	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—LRP1—migraine	7.66e-05	0.00167	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	7.57e-05	0.00165	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—TAC1—migraine	7.56e-05	0.00165	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—NPS—migraine	7.56e-05	0.00165	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR2C—migraine	7.41e-05	0.00162	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—ESR1—migraine	7.35e-05	0.0016	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—MTHFR—migraine	7.34e-05	0.0016	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—PGR—migraine	7.33e-05	0.0016	CbGpPWpGaD
Erlotinib—ABL1—EGF/EGFR Signaling Pathway—FOS—migraine	7.33e-05	0.0016	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—ESR1—migraine	7.31e-05	0.00159	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR1B—migraine	7.24e-05	0.00158	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—EDNRA—migraine	7.21e-05	0.00157	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—RAMP1—migraine	7.19e-05	0.00157	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CALCRL—migraine	7.19e-05	0.00157	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	7.12e-05	0.00155	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR1D—migraine	7.06e-05	0.00154	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CALCA—migraine	7.05e-05	0.00154	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR1A—migraine	6.97e-05	0.00152	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CALCA—migraine	6.94e-05	0.00151	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—NPS—migraine	6.86e-05	0.0015	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—TAC1—migraine	6.86e-05	0.0015	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—NOTCH3—migraine	6.82e-05	0.00149	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR2C—migraine	6.73e-05	0.00147	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2B—migraine	6.56e-05	0.00143	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	6.55e-05	0.00143	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	6.55e-05	0.00143	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—EDNRA—migraine	6.55e-05	0.00143	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR7—migraine	6.49e-05	0.00142	CbGpPWpGaD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	6.48e-05	0.00141	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CALCA—migraine	6.3e-05	0.00137	CbGpPWpGaD
Erlotinib—EGFR—EGF/EGFR Signaling Pathway—FOS—migraine	6.26e-05	0.00137	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	6.24e-05	0.00136	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—TNF—migraine	6.09e-05	0.00133	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	6.09e-05	0.00133	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—FOS—migraine	6.08e-05	0.00133	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR7—migraine	5.89e-05	0.00129	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NOTCH4—migraine	5.88e-05	0.00128	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	5.83e-05	0.00127	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	5.82e-05	0.00127	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	5.82e-05	0.00127	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—LRP1—migraine	5.78e-05	0.00126	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR1D—migraine	5.75e-05	0.00126	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.74e-05	0.00125	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.74e-05	0.00125	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TGFBR2—migraine	5.68e-05	0.00124	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR1B—migraine	5.67e-05	0.00124	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—HTR3A—migraine	5.57e-05	0.00122	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR1A—migraine	5.46e-05	0.00119	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TAC1—migraine	5.38e-05	0.00117	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NPS—migraine	5.38e-05	0.00117	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—PGR—migraine	5.38e-05	0.00117	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2B—migraine	5.35e-05	0.00117	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2C—migraine	5.27e-05	0.00115	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR1D—migraine	5.23e-05	0.00114	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—EDNRA—migraine	5.13e-05	0.00112	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NOTCH3—migraine	5e-05	0.00109	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CALCA—migraine	4.94e-05	0.00108	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—TNF—migraine	4.89e-05	0.00107	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.88e-05	0.00106	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2B—migraine	4.86e-05	0.00106	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—LRP1—migraine	4.71e-05	0.00103	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR7—migraine	4.62e-05	0.00101	CbGpPWpGaD
Erlotinib—MKNK1—Disease—MTHFR—migraine	4.61e-05	0.00101	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TNF—migraine	4.57e-05	0.000997	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—HTR2A—migraine	4.55e-05	0.000992	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NOTCH4—migraine	4.43e-05	0.000967	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TNF—migraine	4.34e-05	0.000946	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR1B—migraine	4.28e-05	0.000933	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RAMP1—migraine	4.25e-05	0.000927	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CALCRL—migraine	4.25e-05	0.000927	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CACNA1A—migraine	4.24e-05	0.000925	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—HTR2A—migraine	4.13e-05	0.000901	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR1A—migraine	4.12e-05	0.000898	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.1e-05	0.000894	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—PGR—migraine	4.05e-05	0.000884	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TAC1—migraine	4.05e-05	0.000884	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NPS—migraine	4.05e-05	0.000884	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—TNF—migraine	3.98e-05	0.000868	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFBR2—migraine	3.98e-05	0.000868	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2C—migraine	3.97e-05	0.000867	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CACNA1A—migraine	3.95e-05	0.000862	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—ESR1—migraine	3.91e-05	0.000854	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—EDNRA—migraine	3.87e-05	0.000844	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TNF—migraine	3.86e-05	0.000841	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NOTCH3—migraine	3.77e-05	0.000822	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CALCA—migraine	3.72e-05	0.000812	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	3.71e-05	0.00081	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	3.71e-05	0.00081	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NOTCH4—migraine	3.61e-05	0.000788	CbGpPWpGaD
Erlotinib—EGFR—Disease—LRP1—migraine	3.61e-05	0.000787	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CACNA1A—migraine	3.6e-05	0.000784	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR1B—migraine	3.49e-05	0.000761	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR7—migraine	3.48e-05	0.00076	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.45e-05	0.000753	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR1A—migraine	3.36e-05	0.000732	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TAC1—migraine	3.3e-05	0.000721	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PGR—migraine	3.3e-05	0.000721	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NPS—migraine	3.3e-05	0.000721	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TNF—migraine	3.27e-05	0.000713	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2C—migraine	3.24e-05	0.000707	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HTR2A—migraine	3.23e-05	0.000706	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR1B—migraine	3.17e-05	0.000691	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—TNF—migraine	3.16e-05	0.000689	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—EDNRA—migraine	3.15e-05	0.000688	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1D—migraine	3.09e-05	0.000674	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.07e-05	0.000671	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NOTCH3—migraine	3.07e-05	0.00067	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR1A—migraine	3.05e-05	0.000665	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CALCA—migraine	3.03e-05	0.000662	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TNF—migraine	3.02e-05	0.000658	CbGpPWpGaD
Erlotinib—JAK3—Immune System—FOS—migraine	3.02e-05	0.000658	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—TAC1—migraine	3e-05	0.000655	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—NPS—migraine	3e-05	0.000655	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFBR2—migraine	3e-05	0.000654	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—migraine	2.95e-05	0.000644	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2C—migraine	2.94e-05	0.000642	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—ESR1—migraine	2.87e-05	0.000626	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2B—migraine	2.87e-05	0.000626	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—EDNRA—migraine	2.86e-05	0.000625	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR7—migraine	2.84e-05	0.000619	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CALCA—migraine	2.76e-05	0.000601	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—FOS—migraine	2.65e-05	0.000579	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR7—migraine	2.58e-05	0.000563	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CACNA1A—migraine	2.58e-05	0.000562	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LRP1—migraine	2.53e-05	0.000551	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFBR2—migraine	2.44e-05	0.000533	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HTR2A—migraine	2.44e-05	0.000532	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CACNA1A—migraine	2.43e-05	0.000531	CbGpPWpGaD
Erlotinib—EGFR—Disease—CALCA—migraine	2.33e-05	0.000507	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—FOS—migraine	2.27e-05	0.000494	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CACNA1A—migraine	2.23e-05	0.000487	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CACNA1A—migraine	2.22e-05	0.000484	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—ESR1—migraine	2.16e-05	0.000472	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HTR2A—migraine	1.99e-05	0.000434	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CACNA1A—migraine	1.94e-05	0.000424	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOTCH4—migraine	1.94e-05	0.000423	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFBR2—migraine	1.87e-05	0.000409	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1B—migraine	1.87e-05	0.000408	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CACNA1A—migraine	1.83e-05	0.0004	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—HTR2A—migraine	1.81e-05	0.000394	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR1A—migraine	1.8e-05	0.000393	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TAC1—migraine	1.77e-05	0.000387	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PGR—migraine	1.77e-05	0.000387	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NPS—migraine	1.77e-05	0.000387	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ESR1—migraine	1.76e-05	0.000385	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2C—migraine	1.74e-05	0.000379	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EDNRA—migraine	1.69e-05	0.000369	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOTCH3—migraine	1.65e-05	0.00036	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CALCA—migraine	1.63e-05	0.000355	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—migraine	1.61e-05	0.000352	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CACNA1A—migraine	1.55e-05	0.000339	CbGpPWpGaD
Erlotinib—ABL1—Immune System—FOS—migraine	1.54e-05	0.000337	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR7—migraine	1.52e-05	0.000332	CbGpPWpGaD
Erlotinib—EGFR—Disease—MTHFR—migraine	1.52e-05	0.000332	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.49e-05	0.000325	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MTHFR—migraine	1.4e-05	0.000306	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—migraine	1.38e-05	0.000301	CbGpPWpGaD
Erlotinib—EGFR—Immune System—FOS—migraine	1.32e-05	0.000288	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFBR2—migraine	1.31e-05	0.000286	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MTHFR—migraine	1.31e-05	0.000285	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CACNA1A—migraine	1.2e-05	0.000261	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—migraine	1.19e-05	0.000259	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HTR2A—migraine	1.07e-05	0.000233	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ESR1—migraine	9.47e-06	0.000207	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—migraine	8.52e-06	0.000186	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—migraine	8.05e-06	0.000176	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—migraine	7.38e-06	0.000161	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—migraine	7.34e-06	0.00016	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—migraine	6.43e-06	0.00014	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—migraine	6.06e-06	0.000132	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—migraine	5.13e-06	0.000112	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—migraine	3.96e-06	8.64e-05	CbGpPWpGaD
